Nasdaq

Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance

TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...
Seeking Alpha

Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst

Wave Life Sciences (WVE) announced positive results from its phase 1b/2a RestorAAtion-2 study using WVE-006 for the treatment of patients with alpha-1 antitrypsin deficiency [AATD]. It was shown that ...
Seeking Alpha

Wave stock soars 73% on positive data for RNA editing treatment (update)

Wave Life Sciences (NASDAQ:WVE) shares soared 73% Wednesday afternoon after the company announced positive proof-of-mechanism data from its Phase 1b/2a RestoraAATion-2 study for its RNA editing ...
Nasdaq

Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington ...

Wave to engage regulators on a clinical development path for WVE-003 that would support a potential accelerated approval, and will submit its opt-in package to program partner Takeda Data provide ...